What can decades of stop-loss history teach brokers about today’s level-funded health plans—and the risks behind an attractive quote?

Tom Stein welcomes veteran actuary Hobson Carroll to The Noble Agents for a conversation about the origins of small-group level funding, the mechanics of retained risk, and the lessons behind past insurance market corrections.

Drawing on his experience dating back to the 1970s, Hobson explains how specific and aggregate stop-loss work together, why precise definitions matter, and how aggressive pricing can create problems that surface at renewal. Tom and Hobson also examine AI underwriting, the declining predictive value of initial medical underwriting, and the financial challenges posed by multimillion-dollar medical treatments.

In this episode:

• How early small-group product development helped shape level funding.
• What past stop-loss market corrections reveal about pricing and underwriting discipline.
• Why gross and net loss ratios can tell very different stories.
• Questions brokers should ask about AI underwriting and renewal sustainability.
• How alternative risk arrangements can give employers more meaningful choices.

Hobson’s advice to brokers: work with your underwriting partners, ask for options, and learn to explain those options clearly. For agents serving Main Street employers, this episode offers a deeper understanding of the products they recommend—and the responsibility that comes with recommending them.

Follow The Noble Agents for more conversations about level funding, employee benefits, and responsible plan stewardship.